Epidemiology, Clinical Characteristics and Cause-specific Outcomes in Heart Failure with Preserved Ejection Fraction

Heart failure (HF) is a global pandemic affecting 64 million people worldwide. HF with preserved ejection fraction (HFpEF) has traditionally received less attention than its main counterpart, HF with reduced ejection fraction (HFrEF). The incidence and prevalence of HFpEF show geographic variation a...

Descripción completa

Detalles Bibliográficos
Autores principales: Kapelios, Chris J, Shahim, Bahira, Lund, Lars H, Savarese, Gianluigi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Radcliffe Cardiology 2023
Materias:
Clinical Syndromes
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10680134/
https://www.ncbi.nlm.nih.gov/pubmed/38020671
http://dx.doi.org/10.15420/cfr.2023.03
Descripción
Sumario:Heart failure (HF) is a global pandemic affecting 64 million people worldwide. HF with preserved ejection fraction (HFpEF) has traditionally received less attention than its main counterpart, HF with reduced ejection fraction (HFrEF). The incidence and prevalence of HFpEF show geographic variation and are increasing over time, soon expected to surpass those of HFrEF. Morbidity and mortality rates of HFpEF are considerable, albeit lower than those of HFrEF. This review focuses on the burden of HFpEF, providing contemporary data on epidemiology, clinical characteristics and comorbidities, cause-specific outcomes, costs and pharmacotherapy.

Ejemplares similares